GOST ISO 14971-2011 PDF
Name in English:
GOST ISO 14971-2011
Name in Russian:
ГОСТ ISO 14971-2011
Medical devices. Application of risk management to medical devices
Full title and description
GOST ISO 14971-2011 — "Изделия медицинские. Применение менеджмента риска к медицинским изделиям" (English: Medical devices — Application of risk management to medical devices). This is the Russian national / interstate adoption of the international standard ISO 14971 (2007 edition) setting out a risk management process for medical devices, including in vitro diagnostic devices.
Abstract
GOST ISO 14971-2011 specifies requirements and guidance for a manufacturer’s risk management process across the entire life cycle of a medical device: hazard identification, risk analysis, risk evaluation, risk control, evaluation of overall residual risk versus benefit, and post-production monitoring. It is an identical (IDT) adoption of ISO 14971:2007 and was later replaced in national practice by a 2021 edition aligned with ISO 14971:2019.
General information
- Status: National / interstate adoption of ISO 14971:2007 (IDT); later superseded by GOST ISO 14971-2021 in national practice.
- Publication date: Designation year 2011 (GOST ISO 14971-2011); registry/edition entries and national publication records show related document activity and republic-level enaction dates between 2011 and 2014 (see national record).
- Publisher: Adopted/published through the GOST / national standards system (Rosstandart / interstate standards bodies); developer listed as VNIINMASH for the Russian text.
- ICS / categories: 11.040.01 — Healthcare technology; medical equipment.
- Edition / version: GOST ISO 14971-2011 (IDT to ISO 14971:2007).
- Number of pages: Typically published in Russian as 69 pages (publisher/vendor records list 69 pages for the GOST text).
Scope
The standard establishes a structured risk management process for medical device manufacturers covering all life-cycle stages (design, production, distribution, installation, use, maintenance, and post-production monitoring). It applies to medical devices including in vitro diagnostics, does not itself set acceptable risk levels, does not replace clinical decision-making, and does not by itself require a QMS (though risk management may be part of a manufacturer’s quality management system).
Key topics and requirements
- Establish and maintain a documented risk management process (risk management plan and responsibilities).
- Hazard identification and foreseeable misuse analysis for the device throughout its life cycle.
- Risk analysis and estimation (severity and probability) and use of appropriate risk-estimation techniques.
- Risk evaluation against acceptance criteria and identification of necessary risk control measures.
- Implementation and verification of risk control measures, and assessment of residual risk.
- Risk–benefit analysis where residual risk remains; documenting rationale for acceptability.
- Production and post-production activities: monitoring, data collection, and feedback to update the risk-management file.
- Maintenance of a risk management file / records that demonstrate conformity with the standard’s process requirements.
Typical use and users
Primary users are medical device manufacturers (design and regulatory teams), risk managers, quality managers, clinical engineers, and regulatory authorities/assessment bodies that review conformity evidence. The standard is used to establish device-specific risk management processes, produce a risk management file for regulatory submissions, and guide post-market surveillance and change-control activities.
Related standards
Key related documents include ISO 14971 (international text), ISO/TR 24971 (guidance on the application of ISO 14971), ISO 13485 (medical device quality management systems), IEC 62304 (medical device software lifecycle), IEC 60601 series (medical electrical equipment safety), ISO 10993 series (biocompatibility), and ISO 14155 (clinical investigation of medical devices). National GOST adaptations and harmonized standards referencing ISO 14971 are commonly linked in regulatory frameworks.
Keywords
risk management; medical devices; hazard identification; risk analysis; risk control; residual risk; risk–benefit analysis; risk management file; post-market surveillance; ISO 14971.
FAQ
Q: What is this standard?
A: GOST ISO 14971-2011 is the Russian national/interstate adoption of ISO 14971 (2007) that defines a risk management process for medical devices. It provides requirements for how manufacturers identify hazards, estimate and evaluate risks, control those risks, and monitor effectiveness.
Q: What does it cover?
A: It covers the full life-cycle risk management process for medical devices (including IVDs): planning, hazard identification, risk estimation and evaluation, risk control and verification, residual risk assessment and risk–benefit analysis, and post-production monitoring and feedback. It does not set numeric risk acceptance levels or substitute clinical decision-making.
Q: Who typically uses it?
A: Device manufacturers (design, regulatory and quality teams), risk managers, conformity assessment bodies, notified/registration authorities, clinical engineers and consultants preparing regulatory submissions or implementing risk management systems.
Q: Is it current or superseded?
A: GOST ISO 14971-2011 reflects ISO 14971:2007 and has been superseded in national practice by a later GOST adoption aligned with ISO 14971:2019 (published as GOST ISO 14971-2021). Users working to current international/regulatory expectations should reference the 2019-based national adoption (2021 GOST) where applicable.
Q: Is it part of a series?
A: It is part of the family of medical-device standards and commonly used together with ISO/TR 24971 (guidance), ISO 13485 (QMS for medical devices), the IEC 60601 and IEC 62304 series, ISO 10993 (biocompatibility) and standards for clinical investigations (ISO 14155). These related standards support implementation and regulatory compliance.
Q: What are the key keywords?
A: Risk management; hazard; risk analysis; risk control; residual risk; benefit–risk; risk management file; medical device safety; post-market surveillance.